REDWOOD CITY, CA--(Marketwire -01/06/12)- A.P. Pharma, Inc. (OTC.BB: APPA.OB) - News, a specialty pharmaceutical company, today announced that the Company will present at the OneMedForum San Francisco 2012 Finance Conference on January 11, 2012 at 10:45 a.m. PST. The conference will be held at the Sir Francis Drake Hotel in San Francisco. A.P. Pharma management will provide an overview of recent corporate progress.
About A.P. Pharma
A.P. Pharma is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery technology. The Company's primary focus is on its lead product, APF530, for the prevention of chemotherapy-induced nausea and vomiting (CINV). A.P. Pharma received a Complete Response Letter on the APF530 New Drug Application (NDA) and is targeting the resubmission of the NDA for the first half of 2012. The Company has additional clinical and preclinical stage programs in the area of pain management, all of which utilize its bioerodible, injectable and implantable delivery systems. For further information, please visit the Company's web site at .
Forward-looking Statements
This news release contains "forward-looking
statements" as defined by the Private Securities
Litigation Reform Act of 1995. These forward-looking
statements involve risks and uncertainties, including
uncertainties associated with capital resources and
liquidity, timely development and regulatory approval of
product candidates, satisfactory completion of clinical
studies, progress in research and development programs,
launch and acceptance of new products and other risks and
uncertainties identified in the Company's filings with
the Securities and Exchange Commission. We caution investors
that forward-looking statements reflect our analysis only on
their stated date. We do not intend to update them except as
required by law.
SOURCE: A.P. Pharma, Inc.
Investor Relations
Mike Rice
Office Phone: (646) 597-6979
Mobile Phone: (917) 282-3242
Email: mrice@lifesciadvisors.com
Corporate
A.P. Pharma, Inc.
John B. Whelan
President, Chief Executive Officer and Chief Financial Officer
650-366-2626
distribué par | Ce noodl a été diffusé par AP Pharma Inc. et initialement mise en ligne sur le site http://www.appharma.com. La version originale est disponible ici. Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-06 18:04:31 PM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |